FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1336610 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
1C (AJCC) Acceptable (foundation metadata concept)
1C (UICC) Acceptable (foundation metadata concept)
1D cold incubation Acceptable (foundation metadata concept)
1D post incubation Acceptable (foundation metadata concept)
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase Preferred (foundation metadata concept)
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase (substance) Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 1-kinase Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 1-kinase (substance) Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 5-kinase Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 5-kinase (substance) Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 3-kinase Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 3-kinase (substance) Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 5-kinase Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 5-kinase (substance) Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 6-kinase Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 6-kinase (substance) Preferred (foundation metadata concept)
1E (AJCC) Acceptable (foundation metadata concept)
1E (UICC) Acceptable (foundation metadata concept)
1H post 100 g glucose PO Acceptable (foundation metadata concept)
1H post 50 g glucose PO Acceptable (foundation metadata concept)
1H post 75 g glucose PO Acceptable (foundation metadata concept)
1H post dose corticotropin Acceptable (foundation metadata concept)
1H post dose glucose Acceptable (foundation metadata concept)
1H post incubation Acceptable (foundation metadata concept)
1H post meal Acceptable (foundation metadata concept)
1H post resting Acceptable (foundation metadata concept)
1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase Acceptable (foundation metadata concept)
1H-Benzotriazol Preferred (foundation metadata concept)
1H-Benzotriazol Preferred (foundation metadata concept)
1H-Benzotriazol (product) Preferred (foundation metadata concept)
1H-Benzotriazol (substance) Preferred (foundation metadata concept)
1H-Benzotriazole Acceptable (foundation metadata concept)
1H-Pyrazole-3-ethanamine Acceptable (foundation metadata concept)
1H-Pyrazole-3-ethanamine dihydrochloride Acceptable (foundation metadata concept)
1L-myo-Inositol-1-phosphatase Preferred (foundation metadata concept)
1L-myo-Inositol-1-phosphatase (substance) Preferred (foundation metadata concept)
1LT Acceptable (foundation metadata concept)
1S (AJCC) Acceptable (foundation metadata concept)
1S (UICC) Acceptable (foundation metadata concept)
1SG Acceptable (foundation metadata concept)
1p partial monosomy Preferred (foundation metadata concept)
1p partial monosomy (disorder) Preferred (foundation metadata concept)
1p21.3 microdeletion syndrome Preferred (foundation metadata concept)
1p21.3 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1p31p32 microdeletion syndrome Preferred (foundation metadata concept)
1p31p32 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1p35.2 microdeletion syndrome Preferred (foundation metadata concept)
1p35.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1p36 deletion syndrome Preferred (foundation metadata concept)
1q partial monosomy Preferred (foundation metadata concept)
1q partial monosomy (disorder) Preferred (foundation metadata concept)
1q partial trisomy syndrome Preferred (foundation metadata concept)
1q partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
1q21.1 contiguous gene deletion Acceptable (foundation metadata concept)
1q21.1 microdeletion Preferred (foundation metadata concept)
1q21.1 microdeletion syndrome Acceptable (foundation metadata concept)
1q21.1 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1q21.1 microduplication syndrome Preferred (foundation metadata concept)
1q21.1 microduplication syndrome (disorder) Preferred (foundation metadata concept)
1q41-q42 microdeletion syndrome Acceptable (foundation metadata concept)
1q41q42 microdeletion syndrome Preferred (foundation metadata concept)
1q41q42 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1q41q42 microdeletion syndrome is a chromosomal anomaly characterized by a severe developmental delay and/or intellectual disability, typical facial dysmorphic features, brain anomalies, seizures, cleft palate, clubfeet, nail hypoplasia and congenital heart disease. Preferred (foundation metadata concept)
1q44 microdeletion syndrome Preferred (foundation metadata concept)
1q44 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
1st Acceptable (foundation metadata concept)
1st HiB and DTP vaccine given Preferred (foundation metadata concept)
1st HiB and DTP vaccine given (situation) Preferred (foundation metadata concept)
1st Hib and DTP vaccine given Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination (procedure) Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination (procedure) Preferred (foundation metadata concept)
1st Lt Acceptable (foundation metadata concept)
1st floor Acceptable (foundation metadata concept)
1st heart sound split Acceptable (foundation metadata concept)
1st hepatitis A junior vaccination Acceptable (foundation metadata concept)
1st left lumbar vein Acceptable (foundation metadata concept)
1st right lumbar vein Acceptable (foundation metadata concept)
1st specimen Acceptable (foundation metadata concept)
1st trimester Acceptable (foundation metadata concept)
1stLt Acceptable (foundation metadata concept)
2 Preferred (foundation metadata concept)
2 Preferred (foundation metadata concept)
2 (AJCC) Acceptable (foundation metadata concept)
2 (UICC) Acceptable (foundation metadata concept)
2 (qualifier value) Preferred (foundation metadata concept)
2 ASD - Secundum atrial septal defect Acceptable (foundation metadata concept)
2 bulky (AJCC) Acceptable (foundation metadata concept)
2 bulky (UICC) Acceptable (foundation metadata concept)
2 dimethylaminoethanol Acceptable (foundation metadata concept)
2 female babies Acceptable (foundation metadata concept)
2 fingers Preferred (foundation metadata concept)
2 fingers (qualifier value) Preferred (foundation metadata concept)
2 hour post-prandial blood glucose level Preferred (foundation metadata concept)
2 hour post-prandial blood glucose level Preferred (foundation metadata concept)
2 hour post-prandial blood glucose level (procedure) Preferred (foundation metadata concept)
2 hour post-prandial blood glucose level (procedure) Preferred (foundation metadata concept)
2 hour urine specimen Preferred (foundation metadata concept)
2 hour urine specimen (specimen) Preferred (foundation metadata concept)
2 hourly Acceptable (foundation metadata concept)

Start Previous Page 79 of 13367 Next End

Reference Sets

Reference set descriptor

Back to Start